ArticleProceedings of the ... IEEE/RSJ International Conference on Intelligent Robots and Systems. IEEE/RSJ International Conference on Intelligent Robots and Systems2024
Thermal Ablation Therapy Control with Tissue Necrosis-driven Temperature Feedback Enabled by Neural State Space Model with Extended Kalman Filter.
Article in Proceedings of the ... IEEE/RSJ International Conference on Intelligent Robots and Systems. IEEE/RSJ International Conference on Intelligent Robots and Systems, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Direct-Necrosis-Monitoring-Based Adaptive Model Predictive Control for Ablation Therapy Including Patient-Specific Residual Heat Management.Annals of biomedical engineering · 2026Article
- Opportunities challenges and roadmap for humanoid robots in construction.Scientific reports · 2025Review
- In-bore MRI-compatible transrectal ultrasound and photoacoustic imaging.Photoacoustics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Thermal ablation therapy is a major minimally invasive treatment. One of the challenges is that the targeted region and therapeutic progression are often invisible to clinicians, requiring feedback provided in numerical information or imaging. Several emerging imaging modalities offer visualization of the ablation-induced necrosis formation; however, relying solely on necrosis monitoring can result in tissue overheating and endangering patients. Some of the necrosis monitoring modalities are known for their capabilities in temperature sensing, but the principles on which they are based have several limitations, such as sensitivity to the tissue motion and their environment. In this study, we propose a necrosis progression-based temperature estimation technique as an added safety feature for avoiding overheating. This model-based method does not require additional sensing hardware. It is designed to work as an independent estimator or a complimentary estimation component with other thermometers for improved robustness. For this objective, the Neural State Space model is used to approximate the ablation therapy, whose theoretical models involve nonlinear partial differential equations. Then, the Extended Kalman Filter is designed based on the model. The simulation study shows the estimation module robustly estimates the tissue temperature under several types of noise. The maximum estimation error observed before terminating ablation was around 1 °C, and the desired safety feature was successfully demonstrated. The estimator is expected to be used in a variety of necrosis monitoring modalities to guarantee more precise and safer treatment. More ambitiously, the architecture with the Neural State Space model and Extended Kalman Filter is generalizable to other medical/biological procedures involving nonlinear and patient/environment-specific physics and even to procedures having no reliable theoretical models.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.